Today: 31 May 2026
Groww IPO Day 2: Fully Subscribed (1.47x); Retail 4.65x, GMP 11–15%; Nithin Kamath Says 20% of Applications Came via Zerodha — What Top Brokerages Recommend
17 November 2025
3 mins read

Groww share price hits upper circuit; market cap crosses ₹1 lakh crore on Day 4 post‑IPO rally as CEO Lalit Keshre joins billionaire club (Nov 17, 2025)

Bengaluru/Mumbai | Monday, November 17, 2025 — Online investing platform Groww (listed as Billionbrains Garage Ventures Ltd; NSE: GROWW, BSE: 544603) sprinted to its 20% upper circuit at ₹178.23 in Monday trade, propelling its market capitalisation past ₹1 lakh crore (about ₹1.10 lakh crore) just four sessions after listing. At the day’s high, the stock was ~78% above the ₹100 IPO price, underscoring one of the strongest post‑listing runs for a mainboard IPO this year.

‘Billionaire in four sessions’: Lalit Keshre’s stake swells

The surge has catapulted cofounder‑CEO Lalit Keshre into India’s billionaire club. Economic Times’ calculations peg Keshre’s holding at ~55.9 crore shares, valuing his stake at ~₹9,400 crore at recent prices, while Moneycontrol and India Today also reported his transition to billionaire status following the blockbuster debut.

Why the frenzy? A perfect cocktail of earnings, participation and scarcity value

  • Retail investing boom: The National Stock Exchange has added roughly 10 million investors every 6–7 months since 2021, reaching ~120 million by September 2025—a secular tailwind for brokers and direct‑to‑customer platforms like Groww.
  • Profitability and scale: For FY25, Groww reported ~₹4,056 crore in revenue and ~₹1,819 crore net profit, highlighting operating leverage as it expanded beyond mutual funds into equities, F&O, bonds and more.
  • Dominance premium: With Monday’s spike, Groww is now India’s most‑valued listed broker; LiveMint noted its valuation exceeds the combined market cap of several established peers—a sign of the “category‑leader” scarcity premium investors are willing to pay. mint

What exactly happened today (Nov 17)

  • Price action: Shares locked at ₹178.23 on the upside, marking the fourth straight session of gains since listing on Wednesday, November 12. Intraday moves took the market cap beyond ₹1 lakh crore.
  • Momentum narrative: Multiple outlets tracked the move, with LiveMint calling out the Day‑4 rally and the ₹1 lakh crore threshold; Business Standard’s live price snapshots also reflected the upper‑circuit band into the close.
  • Social pulse: Business TV networks amplified the milestone in real time; CNBC‑TV18’s social feed flagged the ₹1 lakh crore m‑cap breach alongside a double‑digit price jump.

IPO recap: a well‑priced sale, a blowout debut

  • Timeline & size: The ₹6,632‑crore IPO (bookbuilt Nov 4–7, 2025, price band ₹95–₹100) comprised a ₹1,060‑crore fresh issue and ₹5,572.3‑crore OFS, and listed on Nov 12.
  • Subscription: The deal drew strong demand, with overall subscription ~17.05x, led by institutions.
  • Listing day numbers:Opened at ₹112 on NSE, ran up to ₹124–₹134 intraday, and closed around ₹128.85, valuing the company in the ₹760–795 billion range on Day 1.

How today’s surge reshapes the brokerage league table

By eclipsing ₹1 lakh crore, Groww’s parent now sits well ahead of listed broking peers by market value—a striking feat for a platform launched in 2016 that grew by tapping India’s wave of first‑time market entrants with a mobile‑first product. LiveMint’s analysis highlights that the new valuation tops the combined capitalisation of Angel One, Anand Rathi, 5paisa, Nuvama, and JM Financial.

Ticker, codes and where it trades

Investors can track the stock under NSE: GROWW and BSE code: 544603 (ISIN: INE0HOQ01053). Some market data services may also reference a Reuters code separately, but the domestic trading symbol is GROWW.

What analysts say—and what to watch next

While the medium‑term story of financialization remains intact, some analysts caution that near‑term optimism looks priced in and advise watching the next couple of quarters to assess sustainability of growth and monetization. Expect heightened volatility typical of early post‑listing phases and monitor client addition, trading volumes, cross‑sell (MFs, derivatives, bonds), and take‑rates.


Key takeaways (Nov 17, 2025)

  • Groww share price: Hit upper circuit at ₹178.23; m‑cap > ₹1 lakh crore; ~+78% vs IPO price in 4 sessions.
  • Founder wealth: Lalit Keshre now a billionaire; stake valued at ~₹9,400 crore; ~55.9 crore shares disclosed pre‑IPO.
  • IPO math: ₹6,632 crore issue; fresh ₹1,060 crore + OFS ₹5,572.3 crore; price band ₹95–₹100; listed Nov 12 after ~17x subscription.
  • Debut stats: Opened ₹112 (NSE), intraday up to ₹124–₹134, closed ~₹128.85 on Day 1.
  • Macro tailwind: ~120 million NSE investors by Sep 2025 underline the structural growth in retail participation.

Editorial note

This report synthesizes today’s (Nov 17, 2025) developments across leading business outlets tracking Groww’s Day‑4 rally and market‑cap milestone, plus verified IPO and listing‑day data. For investors, the setup remains compelling—but valuations are elevated relative to legacy peers, so position sizing and risk management matter. This article is informational and not investment advice.

Sources: LiveMint, Moneycontrol, Economic Times, Reuters, Business Standard, India Today, and Upstox News.

Stock Market Today

  • Nanobiotix Raises €85 Million to Advance JNJ-1900 Cancer Treatment Amid Volatile Stock Rally
    May 30, 2026, 6:54 PM EDT. Nanobiotix (ENXTPA:NANO) completed a €85 million global equity raise to fund the development of JNJ-1900 (NBTXR3), a leading cancer treatment candidate. The financing follows promising Phase 2 trial results in inoperable non-small cell lung cancer, sponsored by Johnson & Johnson. Despite a recent 6.6% dip, shares have soared over 79% year-to-date, closing at €34.04, reflecting high market sensitivity to company developments. The fundraise attracted both European and U.S. investors through ordinary shares, American Depositary Shares, and pre-funded warrants issued near the current share price, suggesting robust demand without steep discounting. Investors will closely monitor Nanobiotix's clinical progress, regulatory updates, and potential partnerships, amid dilution concerns due to the new equity issue.

Latest articles

Realty Income Stock Dips Ahead of Jobs Data; Dividend Investors Eye Rates

Realty Income Stock Dips Ahead of Jobs Data; Dividend Investors Eye Rates

31 May 2026
Realty Income closed Friday at $61.28, down from $62.02 the previous week, as property stocks lagged broader market gains. The company declared a $0.2705 monthly dividend, payable June 15 to shareholders of record May 29. CEO Sumit Roy will present at Nareit’s REITweek on June 3. Investors await the U.S. May jobs report on June 5.
Oklo Stock Higher After Plutonium-Fuel Update

Oklo Stock Higher After Plutonium-Fuel Update

31 May 2026
Oklo shares closed at $66.88 Friday, down 1.78%, after a week of gains sparked by news the U.S. Department of Energy selected the company for advanced talks on using surplus plutonium as reactor fuel. Trading volume reached 27.67 million shares. Oklo reported a first-quarter net loss of $33.1 million and ended March with $2.54 billion in cash and equivalents.
Cameco Stock Is Back in Focus After a Mine Restart — What Investors Watch Next

Cameco Stock Is Back in Focus After a Mine Restart — What Investors Watch Next

31 May 2026
Cameco shares closed Friday at C$154.91 on the TSX, up 7.1% for the week after full production resumed at McArthur River and Key Lake following flood-related disruptions. The company kept its 2026 uranium output guidance unchanged at 19.5–21.5 million pounds. CIBC and National Bank of Canada maintained “Outperform” ratings. Cameco reported Q1 net earnings of C$131 million earlier in May.
SSE (LON:SSE) edges higher as new sustainability chief starts; SSEN signs housing deals and completes Southampton upgrade — 5 November 2025
Previous Story

SSE Share Price Today, 17 November 2025: FTSE 100 Utility Climbs Again as £33bn Plan, Wind Farm Upgrade and Index Changes Shape Outlook

Lucid Group (LCID) Stock Crashes to New All‑Time Low as Stifel Slashes Target and $875M Debt Deal Closes
Next Story

Lucid Group (LCID) Stock Crashes to New All‑Time Low as Stifel Slashes Target and $875M Debt Deal Closes

Go toTop